Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

According to this study, over the next five years the Substance Abuse Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Substance Abuse Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Substance Abuse Therapeutics market by product type, application, key companies and key regions.

This study considers the Substance Abuse Therapeutics value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Opioid Addiction
Tobacco/Nicotine Addiction
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital & Clinics
Residential (non-hospital)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Substance Abuse Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Substance Abuse Therapeutics market by identifying its various subsegments.
Focuses on the key global Substance Abuse Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Substance Abuse Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Substance Abuse Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.